Imagin tablets are indicated for the treatment of type 2 diabetes mellitus. Clinical studies have shown the promising efficacy of Imagin both as a monotherapy and in combination therapies, with an acceptable safety profile.
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Imagin (Imeglimin) works through dual mechanisms:
At a cellular level, Imeglimin targets mitochondrial dysfunction, a common factor in the development of Type 2 Diabetes (T2D). It helps correct mitochondrial activity, reduces oxidative stress by lowering reactive oxygen species (ROS), and prevents mitochondrial cell death. Imeglimin enhances glucose-stimulated ATP production and increases NAD+ synthesis, further improving insulin action and glucose handling. It has been shown to preserve β-cell mass in rodents with T2D.
This unique mechanism distinguishes Imagin from other diabetes medications like biguanides, sulfonylureas, and GLP-1 receptor agonists.
Type 2 diabetes mellitus
Amplification of Glucose-Stimulated Insulin Secretion (GSIS) and preservation of β-cell mass: Imeglimin enhances the pancreas’s ability to secrete insulin in response to glucose and helps preserve the β-cells, which are critical for insulin production.
Enhanced Insulin Action: It improves the body’s insulin sensitivity, particularly in the liver and skeletal muscles. Imeglimin may also inhibit the liver's glucose output, helping to regulate blood sugar levels more effectively.
On a cellular and molecular level, Imeglimin corrects mitochondrial dysfunction, which is a key factor in the development of Type 2 Diabetes (T2D). Mitochondria play an essential role in energy production and cell function, and dysfunction in these structures can impair insulin action. Imeglimin works by:
By addressing mitochondrial dysfunction, Imeglimin restores proper cellular energy metabolism, a core defect in T2D. This action is unique compared to other diabetes medications like biguanides (e.g., metformin), sulfonylureas, and GLP-1 receptor agonists, which work through different mechanisms.
In essence, Imeglimin targets the root cause of T2D—defective energy metabolism—offering a novel approach to managing the disease.
For adults:
Store below 30°C in a dry place, away from light. Keep all medications out of reach of children.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.